Advertisement

Outcomes of 3D MRI based HDR brachytherapy with hybrid multichannel vaginal cylinder applicator and freehand needles for treatment of vaginal disease

Published:October 17, 2022DOI:https://doi.org/10.1016/j.brachy.2022.09.002

      Abstract

      Freehand needles can be used with multichannel vaginal cylinders (MCVC) to cover vaginal cancer >7 mm thick or with supra-vaginal extension. We report our institutional outcomes using this novel hybrid technique.
      Patients with vaginal malignancies treated with HDR BT using MCVC plus freehand needles from 2014-2021 at our institution were identified. Clinical characteristics, details of brachytherapy, initial response, and overall local control (LC) outcomes were recorded. LC was analyzed via Kaplan-Meier method.
      34 patients were identified with median follow-up 1.9 years. 19 patients had primary endometrial cancer with vaginal recurrence/disease, and remaining had primary vaginal cancer or other primaries. 7 patients had recurrence after previous RT course. 25 patients received EBRT with median dose 45 Gy in 25 fractions, and rest received BT alone. Median HR-CTV D90 for patients treated with EBRT plus BT was 77.4 Gy.
      30 patients had complete local response to BT on initial examination and/or follow-up imaging. 1 and 2-year LC rates in patients without prior RT treated with EBRT + BT were 94.1% and 94.1%, respectively. 1 and 2-year LC rates for those without prior RT were 88.1% and 76.4%, respectively. 1 and 2-year LC rates for those with prior RT were 68.6% and 34.3%, respectively. 1 patient had vaginal laceration requiring surgical repair, and 1 patient developed small bowel obstruction 1 month after BT, with no additional acute grade 3+ toxicities identified.
      Our approach with MCVC plus freehand needles with MRI-based planning was feasible and safe, with excellent initial local response and low rate of serious toxicities.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Beriwal S.
        • Heron D.E.
        • Mogus R.
        • et al.
        High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.
        Radiat Oncol. 2008; 3
        • Sorbe B.
        • Söderström K.
        Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
        Anticancer Research [Internet]. 2013; 33: 241-247
        • Vargo J.A.
        • Kim H.
        • Houser C.J.
        • et al.
        Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
        Radiotherapy and Oncology [Internet]. 2014; 113: 126-131
        • Beriwal S.
        • Demanes J.
        • Erickson B.
        • et al.
        American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer.
        Brachytherapy. 2012; 11: 68-75
        • Glaser S.M.
        • Kim H.
        • Beriwal S.
        Multichannel vaginal cylinder brachytherapy - impact of tumor thickness and location on dose to organs at risk.
        Brachyhtherapy. 2015; 14: 913-918
        • Kamrava M.
        • Alrashidi S.M.
        • Leung E.
        Interstitial brachytherapy for gynecologic malignancies: Complications, toxicities, and management.
        Brachytherapy [Internet]. 2021; 20: 995-1004
        • Guy J.-.B.
        • Falk A.T.
        • Chargari C.
        • et al.
        Thromboembolic events following brachytherapy.
        J Contemp Brachytherapy. 2015; 1: 76-78
        • Prisciandaro J.I.
        • Zhao X.
        • Dieterich S.
        • et al.
        Interstitial high-dose-rate gynecologic brachytherapy: Clinical workflow experience from three academic institutions.
        Seminars in Radiation Oncology [Internet]. 2020; 30: 29-38
        • Vargo J.A.
        • Kim H.
        • Houser C.J.
        • et al.
        Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
        Brachytherapy. 2015; 14: 9-15
        • Dimopoulos J.C.A.
        • Schmid M.P.
        • Fidarova E.
        • et al.
        Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: Dose–volume parameters and first clinical results.
        International Journal of Radiation Oncology*Biology*Physics. 2012; 82: 1880-1888
        • Beriwal S.
        • Rwigema J.-.C.M.
        • Higgins E.
        • et al.
        Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
        Brachytherapy. 2012; 11: 176-180
        • Lee L.J.
        • Damato A.L.
        • Viswanathan A.N.
        Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
        Gynecol. Oncol. 2013; 131: 586-592
        • Ling D.C.
        • Vargo J.A.
        • Glaser S.M.
        • Kim H.
        • Beriwal S.
        Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
        Gynecol. Oncol. 2019; 152: 581-586
        • Manuel M.
        • Cho L.
        • Catalano P.
        • et al.
        Outcomes with Image-based Interstitial Brachytherapy for Vaginal Cancer.
        Radiother Oncol. 2016; 120: 486-492
        • Mahantshetty U.
        • Shrivastava S.
        • Kalyani N.
        • et al.
        Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
        Brachytherapy. 2014; 13: 337-342
        • Beriwal S.
        • Rwigema J.-.C.M.
        • Higgins E.
        • et al.
        Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer–.
        Brachytherapy. 2012; 11: 176-180
        • Kaidar-Person O.
        • Abdah-Bortnyak R.
        • Amit A.
        • et al.
        Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspective.
        Reports of Practical Oncolology & Radiotherapy. 2014; 19: 56-61
        • Murofushi K.N.
        • Tomita T.
        • Ohnishi K.
        • et al.
        Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study.
        Radiat Oncol. 2021; 16
        • Charra-Brunaud C.
        • Harter V.
        • Delannes M.
        • et al.
        Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
        Radiother Oncol. 2012; 103: 305-313